SUKL: Benefits of AstraZeneca's Vaccine Continue to Outweigh Its Risks
Bratislava, April 6 (TASR) – The link between rare serious cases of thromboembolic complications and AstraZeneca’s Vaxzevria vaccine hasn’t been established but is being intensively investigated, State Institute for the Supervision of Medicines (SUKL) spokeswoman Magdalena Jurkemikova told TASR on Tuesday, adding that the benefits of the vaccine continue